| NAME |
LENVATINIB 4MG X 2 (8MG) DAILY PKT |
| VA GENERIC NAME |
LENVATINIB |
| DOSAGE FORM |
CAP,ORAL |
| FORMULARY DESIGNATOR |
PA-F |
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2020-07-15 00:00:00 |
| NATIONAL FORMULARY NAME |
LENVATINIB CAP,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
LENVATINIB 4MG X 2 (8MG) DAILY PKT |
| VA PRODUCT IDENTIFIER |
L0695 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
PKT |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4035798 |
| EFFECTIVE DATE/TIME |
-
- 2016-06-10 00:00:00
- STATUS: ACTIVE
-
- 2020-07-15 00:00:00
- STATUS: INACTIVE
|
